Iradimed Corp (IRMD): Cost of Revenue

Annual figures by period end, from SEC filings.

$19.49M
Year ended 2025-12-31
+17.5%
3-year compound annual growth
+19.1%
5-year compound annual growth
+12.8%
10-year compound annual growth
2013-12-31: $2.85M2014-12-31: $3.40M2015-12-31: $5.84M2016-12-31: $6.15M2017-12-31: $5.57M2018-12-31: $7.21M2019-12-31: $8.82M2020-12-31: $8.14M2021-12-31: $9.76M2022-12-31: $12.02M2023-12-31: $15.40M2024-12-31: $16.89M2025-12-31: $19.49M$19.49M
2013-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$19.49M+15.4%2026-03-06, From 2025-01-01
2024-12-31$16.89M+9.7%2026-03-06, From 2024-01-01
2023-12-31$15.40M+28.1%2025-09-03, From 2023-01-01
2022-12-31$12.02M+23.1%2024-03-01, From 2022-01-01
2021-12-31$9.76M+19.9%2023-03-02, From 2021-01-01
2020-12-31$8.14M-7.6%2022-03-04, From 2020-01-01
2019-12-31$8.82M+22.2%2022-03-04, From 2019-01-01
2018-12-31$7.21M+29.5%2021-03-05, From 2018-01-01
2017-12-31$5.57M-9.5%2020-03-06, From 2017-01-01
2016-12-31$6.15M+5.4%2019-03-07, From 2016-01-01
2015-12-31$5.84M+71.6%2018-03-08, From 2015-01-01
2014-12-31$3.40M+19.3%2017-03-10, From 2014-01-01
2013-12-31$2.85Mn/a2015-03-23, From 2013-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Iradimed Corp (IRMD)2025-12-31$19.49M+15.4%
Delcath Systems, Inc. (DCTH)2025-12-31$11.80M+90.6%
Pulmonx Corp (LUNG)2025-12-31$23.36M+7.2%
PRO DEX Inc (PDEX)2026-06-30$53.21M+13.0%
Sight Sciences, Inc. (SGHT)2025-12-31$10.70M-7.6%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$46.26M+29.9%
AVITA Medical, Inc. (RCEL)2025-12-31$12.79M+40.7%
NeuroPace Inc (NPCE)2025-12-31$22.77M+9.3%
Beta Bionics, Inc. (BBNX)2025-12-31$44.71M+52.9%

Compare IRMD, DCTH, LUNG, PDEX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗